How much has Intel raised?

Intel has never raised private venture capital or private equity funding. The company went public in October 1971 — just three years after its founding — at $23.50 per share on the newly formed NASDAQ exchange, raising $6.8 million. At the time, it was a pioneering move; NASDAQ itself had only launched that year. The founding team of Robert Noyce, Gordon Moore, and Andy Grove retained significant equity and funded early operations through a $2.5 million seed from Arthur Rock and other angel backers prior to the IPO, but there were no institutional venture rounds in the modern sense.

Since the IPO, Intel has funded itself entirely through retained earnings, public equity, and investment-grade bond issuances. Its largest capital deployments — Altera ($16.7B, 2015) and Mobileye ($15.3B, 2017) — were funded through a combination of cash on hand and public debt markets at rates available only to investment-grade borrowers. The company has periodically issued equity in connection with employee stock programs but has not conducted a primary equity raise since the IPO.

Today, the most significant non-dilutive capital event in Intel's history is structural rather than financial: the US CHIPS and Science Act has made Intel eligible for $7.86 billion in finalized direct grants and up to $11 billion in subsidized federal loans for domestic manufacturing expansion in Arizona, New Mexico, Ohio, and Oregon. These are non-dilutive and tied to specific capital expenditure commitments on US soil.

As a mega-cap NASDAQ constituent, Intel's shareholder base is dominated by passive institutional asset managers. Vanguard Group and BlackRock consistently rank as the two largest shareholders, each holding approximately 8–9% of shares outstanding. State Street, Geode Capital Management, and Fidelity Management & Research round out the top five. These are index holders whose positions move primarily with index rebalancing rather than active conviction.

Meaningfully, Silver Lake — one of the world's largest technology-focused private equity firms — took a 51% controlling stake in Intel's Altera subsidiary in September 2025 at an $8.75 billion valuation, making it Intel's most prominent active private capital partner. The deal valued Altera at roughly half what Intel paid in 2015, reflecting the FPGA unit's underperformance ($1.54B revenue and a $615M operating loss in 2024). Altera now operates semi-independently with its own board and CEO, targeting a future IPO.

Intel continues to hold majority voting control of Mobileye (MBLY) through super-voting Class B shares representing ~96.9% of total voting power, even as Intel has sold down its economic stake via secondary offerings throughout 2025. Intel has also been gradually reducing Mobileye ownership through open market sales, providing periodic liquidity.

Intel's stock hit a 52-week low of $18.97 in late 2024 — down from multi-year highs above $50 — as the market punished the company for losing manufacturing leadership to TSMC, missing AI GPU opportunities, and failing to hit process node targets under CEO Pat Gelsinger. At its nadir, Intel's market cap fell below $80 billion — a remarkable compression for a company that once commanded 30–40x forward earnings multiples.

The recovery to approximately $134 per share (market cap ~$672 billion) by June 2026 was driven by several compounding catalysts: Lip-Bu Tan's appointment in March 2025 signaled a credible operational reset; Intel 18A achieving production-quality yields ahead of expectations during H2 2025; Q1 2026 results beating guidance by $1.4 billion with non-GAAP gross margins of ~41% (650 basis points above guidance); and the broader AI infrastructure boom lifting semiconductor stocks. The Q1 2026 earnings release sent INTC up 24% in a single session — its largest one-day gain since 1987.

The cumulative twelve-month return to June 2026 is approximately 506%, driven by genuine fundamental progress rather than multiple expansion alone. The turnaround is not yet complete — Intel Foundry remains loss-making and external revenue is nascent at $174M per quarter — but the manufacturing thesis is working and investor confidence has been substantially rebuilt.

Intel posted a GAAP net loss in FY2025 on a full-year basis due to heavy depreciation, restructuring charges (approximately $1.9 billion in FY2025 restructuring costs), and Intel Foundry's ongoing ramp losses. On a non-GAAP basis, the picture is improving: full-year FY2025 non-GAAP gross margin was approximately 36%, and Q1 2026 non-GAAP gross margin reached approximately 41%. Non-GAAP EPS for FY2025 was $0.42. Management guided Q2 2026 revenue of $13.8B–$14.8B, well above pre-earnings consensus.

The balance sheet reflects Intel's scale: as of Q4 2025, Intel held approximately $8.25 billion in cash and equivalents (plus additional short-term investments bringing total liquid assets above $37 billion). Total assets were approximately $204 billion as of Q3 2025, with stockholders' equity of approximately $117 billion. The company generated $9.7 billion in operating cash flow for full-year FY2025, demonstrating continued cash generation capacity despite reported losses.

There is no credible scenario of Intel going private — it is a designated US strategic asset under CHIPS Act commitments requiring domestic manufacturing, and its ~$672B market cap dwarfs any conceivable leveraged buyout. Structural questions that remain open include whether Intel will fully divest Mobileye (ongoing stake sales suggest yes, eventually) and whether Intel Foundry may eventually be carved out as a separate entity — something management has not ruled out as external customer wins accumulate.

Intel's improving balance sheet and CHIPS Act grant disbursements are actively funding new capital programs throughout 2025–2026. The Intel Foundry manufacturing ramp requires significant vendor spend — equipment suppliers, materials companies, facility services, and engineering services providers are all active categories. New hires in Intel Foundry (despite overall headcount reductions in other groups), expanded AI software tooling, and enterprise IT modernization driven by Lip-Bu Tan's return-to-office and operational rigor mandates are areas where budget availability has improved.

For sellers targeting Intel, the procurement landscape has changed under Tan's leadership. He has a reputation from his Cadence years for demanding vendor accountability and operational rigor. Decisions above roughly $1M typically require sign-off from the relevant business unit General Manager and a Finance Business Partner; deals above $5M often require EVP approval. Intel Foundry and Intel Products now operate as separate entities with distinct procurement organizations — the right entry point depends heavily on which group is the buyer.

The highest-impact vendor targets in 2026 are Intel Foundry (receiving concentrated CHIPS Act investment and ramp spending) and the DCAI group (growing 22% year-over-year on AI server demand). European sellers should prioritize the Leixlip, Ireland site (Fab 34); Asia-Pacific sellers should target Penang, Malaysia (Intel's largest assembly and test hub). For enterprise software and SaaS, the CCG and central IT organization in Santa Clara and Hillsboro remain the primary buyers.